Webinar CME session: “Non-invasive Monitoring and Treatment of Inflammatory Bowel Disease (IBD) – what the GP needs to know in 2022” & “Chronic nausea and vomiting”

GPs and primary healthcare practitioners will hear a presentation from Dr Chris Cederwall (Gastroenterologist) and Dr Caroline Di Jiang (Gastroenterologist and Endoscopist) about  Gastroenterology through a Webinar.

Date: Thursday 17 March 2022
Time: 6.45 pm – 8.30pm
Location: Webinar via Teams

Learning outcomes:

• Clinical symptoms can be poorly correlated with disease activity, and objective interval assessments with treatment optimization is key to achieving good IBD outcomes
• Non-invasive monitoring is safe and acceptable for the patient, and is especially important in the Covid-19 era
• From 01 March 2022, Amgevita will be the main funded brand of the anti-TNF Adalimumab, and most patients currently on Humira will be switched over to Amgevita

Please click here to register yourself or click register on the right hand side of the page and one of our team member will register you. Please watch out for your confirmation email in both spam/junk folders as the Teams link is included in that email. If there are any issues please email to marketing@evolutioncare.com.